Detalles de la búsqueda
1.
3-year invasive disease-free survival with chemotherapy de-escalation using an 18F-FDG-PET-based, pathological complete response-adapted strategy in HER2-positive early breast cancer (PHERGain): a randomised, open-label, phase 2 trial.
Lancet
; 403(10437): 1649-1659, 2024 Apr 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38582092
2.
Immune-Related Adverse Event Likelihood Score Identifies "Pure" IRAEs Strongly Associated With Outcome in a Phase I-II Trial Population.
Oncologist
; 29(2): e266-e274, 2024 Feb 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37715957
3.
Baseline Tumor Size as Prognostic Index in Patients With Advanced Solid Tumors Receiving Experimental Targeted Agents.
Oncologist
; 29(1): 75-83, 2024 Jan 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37548439
4.
Correlation between trophoblast cell-surface antigen-2 (Trop-2) expression and pathological complete response in patients with HER2-positive early breast cancer treated with neoadjuvant docetaxel, carboplatin, trastuzumab, and pertuzumab.
Breast Cancer Res Treat
; 205(3): 589-598, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38456970
5.
Systemic Treatment of Ductal Carcinoma In Situ of the Breast.
Chirurgia (Bucur)
; 116(5 Suppl): S97-S104, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34967317
6.
Cyclin dependent kinase 4/6 inhibitors in early breast cancer: what is the role of Ki-67?
Lancet Oncol
; 23(3): 325-328, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35240079
7.
Beyond PD(L)-1 Blockade in Microsatellite-Instable Cancers: Current Landscape of Immune Co-Inhibitory Receptor Targeting.
Cancers (Basel)
; 16(2)2024 Jan 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38254772
8.
Tumor Infiltrating Lymphocytes across Breast Cancer Subtypes: Current Issues for Biomarker Assessment.
Cancers (Basel)
; 15(3)2023 Jan 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-36765724
9.
Targeting Post-Translational Modifications to Improve Combinatorial Therapies in Breast Cancer: The Role of Fucosylation.
Cells
; 12(6)2023 03 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36980181
10.
The CDK4/6 inhibitors biomarker landscape: The most relevant biomarkers of response or resistance for further research and potential clinical utility.
Crit Rev Oncol Hematol
; 192: 104148, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37783318
11.
The rare entity of gastrointestinal leiomyosarcomas: An Italian multicenter retrospective study in high-volume referral centers.
Cancer Med
; 12(16): 17047-17055, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37455549
12.
Investigational immunomodulatory drugs for enhancement of triple negative breast cancer (TNBC) immunotherapy: early phase development.
Expert Opin Investig Drugs
; 31(6): 499-513, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-34569405
13.
Targeting Cellular Components of the Tumor Microenvironment in Solid Malignancies.
Cancers (Basel)
; 14(17)2022 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36077813
14.
Emerging treatment landscape of non-muscle invasive bladder cancer.
Expert Opin Biol Ther
; 22(6): 717-734, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35634893
15.
Targeting brain metastases in breast cancer.
Cancer Treat Rev
; 103: 102324, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34953200
16.
Histology-agnostic approvals for antibody-drug conjugates in solid tumours: is the time ripe?
Eur J Cancer
; 171: 25-42, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35696887
17.
Challenges and Obstacles in Applying Therapeutical Indications Formulated in Molecular Tumor Boards.
Cancers (Basel)
; 14(13)2022 Jun 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-35804968
18.
Comparison of real-world data (RWD) analysis on efficacy and post-progression outcomes with pembrolizumab plus chemo vs chemo alone in metastatic non-squamous non-small cell lung cancer with PD-L1 < 50.
Front Oncol
; 12: 980765, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36033444
19.
Continuous sunitinib schedule in advanced platinum refractory thymic epithelial neoplasms: A retrospective analysis from the ThYmic MalignanciEs (TYME) Italian collaborative group.
Eur J Cancer
; 174: 31-36, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35970033
20.
Research and Clinical Landscape of Bispecific Antibodies for the Treatment of Solid Malignancies.
Pharmaceuticals (Basel)
; 14(9)2021 Aug 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-34577584